Buy or sell Baxter International stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Baxter International Stock

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people.

About Baxter International Stock

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Management

Senior Manager, International Pricing & Tender Strategy

Richard Waygood

Corporate Vice President and Chief Financial Officer

James K. Saccaro

Corporate Officers

Brik V. Eyre

Executive Officers

Robert J. Hombach

CIO, Baxter Healthcare

John Parker

Global Chief Privacy Officer

Abhishek Agarwal

Executive Officers

David P. Scharf

Executive Officers

Phillip L. Batchelor

Corporate Officers

Mary Kay Ladone

Bristol - Myers Squibb

Ana Koenig

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Baxter International or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo